Medidata Study Experience
-
Patient-Level Clinical Trial Data + Real World Data
9/6/2022
Future-proof your clinical trial and enhance your evidence generation activities with Medidata Link, which allows sponsors to collect clinical trial data and link it at the patient level to real-world data (RWD).
-
The Next Generation Of Clinical Trial Data Management Software
9/6/2022
Find out how the linking of clinical and real-world data (RWD) lets sponsors power the next generation of clinical development and accelerate evidence generation activities.
-
How Data Impacts GBM/RGB Clinical Trials?
8/25/2022
In this video, Elizabeth Lamont, Senior Medical Director for Medidata AI, describes how an external control arm can be used in rGBM/GBM and the advantages of using an AI SCA, built upon historical clinical trial data.
-
Insights Into Clinical Trial Enrollment
5/18/2022
Explore the continued impact of the pandemic on clinical trial enrollment in Phase II and III studies to help the industry navigate the dynamic landscape in 2022 across four therapeutic areas (TAs).
-
Characterizing The Use Of External Controls For Augmenting Randomized Control Arms And Confirming Benefit
4/19/2022
Learn several approaches to constructing an external control while considering the use of hybrid designs that supplement or augment the control group in the randomized control trials (RCT) with data from an external population.
-
Stronger Data. Smarter Decisions
4/18/2022
Learn how strong data and strong analytics can help companies design and run better trials during the most complex clinical trial landscape in history.
-
Characteristics Of A Scalable Real-World And Clinical Trial Data Linkage Solution
3/16/2022
In this blog, explore how data linkage is a cutting-edge innovation that unlocks a new frontier of enhanced evidence generation by linking clinical trial data (CTD) with real-world data (RWD) at the patient level.
-
Best Practices For Gaining Stakeholder Buy-In For Data Linkage In Clinical Trials
3/16/2022
Data linkage methodologies bridge the gaps between clinical trial data (CTD) and real-world data (RWD). However, while the value of data linkage may be apparent to some, gaining patient, investigator, and internal organizational buy-in presents a barrier to evangelizing and championing data linkage.